Himaja Dutt Chigurupati

Himaja Dutt Chigurupati

Auto-generated profile, based on publicly available information

Himaja Dutt Chigurupati


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2023 in World Journal of Virology
Verified
Journal Article
Open access
GJGowthami Sai Kogilathota Jagirdhar
Gowthami Sai Kogilathota Jagirdhar
YPYashwitha Sai Pulakurthi
Yashwitha Sai Pulakurthi
HCHimaja Dutt Chigurupati
Himaja Dutt Chigurupati
Salim SuraniSalim Surani
Salim Surani
Gastrointestinal tract and viral pathogens

10 October 2025 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
MAMuhammad Ahmed
Muhammad Ahmed
SSShaheer Bin Shafiq
Shaheer Bin Shafiq
JRJunaid Razzak
Junaid Razzak
KMKhubaib Tariq Mansoor
Khubaib Tariq Mansoor
MNMuhammad Abdullah Naveed
Muhammad Abdullah Naveed
SNSivaram Neppala
Sivaram Neppala
Background Stroke is a leading cause of death in the U.S., with mortality trends influenced by hyperlipidemia, a significant risk factor for atherosclerosis and cardiovascular disease that can lead to ischemic stroke. This analysis examines stroke-related mortality in hyperlipidemia among adults aged 25 and older from 1999 to 2023. Methods A retrospective analysis of CDC WONDER investigated trends in mortality from Stroke (ICD codes: I60-I69) among Hyperlipidemia patients (ICD codes: E78.0, E78.1, E78.3, E78.4, E78.5) aged 25 and older. Joinpoint regression analysis calculated age-adjusted mortality rates (AAMR) per 100,000 individuals, annual percentage changes (APC), Average Annual Percent Change (AAPC), and 95% confidence intervals. Results Between 1999 and 2023, stroke and hyperlipidemia caused 241,308 deaths, with AAMRs of 1.38 in 1999 and 7.46 in 2023, an AAPC of + 7.16 (95% CI: 6.66 to 8.52). Adult men had higher AAMRs than women, with increases for both sexes [AAPC: + 7.20 vs. + 7.10; p < 0.001]. Black individuals had the highest AAMRs, followed by Hispanics. AAMR rose for all races, notably for Blacks/African Americans (AAPC: + 8.63%) and adults aged 65 and above (AAPC: + 7.35%). Northeast regions have the highest AAMRs, with the Midwest showing the most significant rise (AAPC: + 7.86%). AAMRs varied by state, from 2.0 in Georgia to 9.43 in Vermont in 2023. Non-metropolitan areas had higher AAMRs (4.31) than metropolitan areas (3.54). Conclusion This analysis reveals significant demographic and racial disparities in Stroke mortality among U.S. adults with Hyperlipidemia, which highlights the urgent need for targeted, equity-focused interventions to address these disparities.

26 January 2026 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
TATalha Ali
Talha Ali
LKLaksh Kumar
Laksh Kumar
FIFaiqa Iqbal
Faiqa Iqbal
SRSyed Hussain Ahmed Rizvi
Syed Hussain Ahmed Rizvi
MZMuhammad Abdullah Naveed Uz Zafar
Muhammad Abdullah Naveed Uz Zafar
SNSivaram Neppala
Sivaram Neppala
Background: Diabetes mellitus significantly elevates the risk of sepsis and exacerbates its clinical outcomes, leading to increased mortality rates. Despite the importance of this association, the demographic and geographic patterns influencing it remain inadequately understood. Methods: Utilizing data from CDC WONDER (1999–2020), we conducted an analysis of mortality trends among U.S. adults aged 65 and older, stratified by gender, race/ethnicity, and geographic region. Age-adjusted mortality rates (AAMRs) and annual percentage changes (APCs) were evaluated using the Joinpoint Regression methodology. Results: Between 1999 and 2020, there were a total of 287,738 deaths attributed to diabetes and sepsis. The AAMR decreased from 33.6 per 100,000 population in 1999 to 27.7 in 2014; however, it subsequently surged to 38.4 by 2020 (APC: 13.65). The male AAMRs reached a peak of 39.1 in 2005, declined to 31.2 in 2012, and then increased to 46.9 in 2020 (APC 12.29). Female AAMRs decreased from 32.6 in 1999 to 24.8 in 2018, before rising again to 31.9 in 2020 (APC 13.66). Among African Americans, mortality declined to 46.3 in 2019 but experienced a sharp increase to 65.7 in 2020 (APC 20.52). The Hispanic AAMR also increased during this period (APC 25.05). The southern region consistently exhibited the highest mortality rates, rising from 31.7 in 2018 to 42.5 in 2020 (APC 13.69), with notable rises observed in the Midwest (APC 14.59). All these trends were statistically significant ( p < 0.05). Furthermore, non-metropolitan areas consistently demonstrated higher mortality rates, with significant increases observed between 2018 and 2020. Conclusion: The mortality rates associated with diabetes-related sepsis have recently risen, particularly between 2018 and 2020, thereby highlighting significant health disparities. It is essential to implement targeted healthcare interventions.

6 August 2025 in Journal of Clinical Lipidology
Verified
Journal Article
Open access
SWShariq Ahmad Wani
Shariq Ahmad Wani
MNMuhammad Abdullah Naveed
Muhammad Abdullah Naveed
AAAhila Ali
Ahila Ali
ASAnzel Saeed
Anzel Saeed
BABazil Azeem
Bazil Azeem
SNSivaram Neppala
Sivaram Neppala

14 February 2024 in Obesity Pillars
Verified
Journal Article
Open access
SNSivaram Neppala
Sivaram Neppala
HCHimaja Dutt Chigurupati
Himaja Dutt Chigurupati
NMNikhilender Nag Mopuru
Nikhilender Nag Mopuru
NANaga Ruthvika Alle
Naga Ruthvika Alle
AJAlpha James
Alpha James
RDRupak Desai
Rupak Desai
Body Mass Index (BMI) has a significant impact on Coronavirus disease (COVID-19) patient outcomes; however, major adverse cardiac and cerebrovascular outcomes in patients with severe sepsis have been poorly understood. Our study aims to explore and provide insight into its association. This is an observational study looking at the impact of BMI on COVID-19-severe sepsis hospitalizations. The primary outcomes are adjusted odds of all-cause in-hospital mortality, respiratory failure, and major adverse cardiac and cerebrovascular events (MACCE), which include acute myocardial infarction, cardiac arrest, and acute ischemic stroke. The secondary outcome was healthcare resource utilization. Coexisting comorbidities and patient features were adjusted with multivariable regression analyses. Of 51,740 patients with severe COVID-19-sepsis admissions, 11.4% were overweight, 24.8% had Class I obesity (BMI 30–34.9), 19.8% had Class II obesity (BMI 35–39.9), and 43.9% had the categorization of Class III obesity (BMI >40) cohorts with age>18 years. The odds of MACCE in patients with class II obesity and class III obesity (OR 1.09 and 1.54; 95CI 0.93–1.29 and 1.33–1.79) were significantly higher than in overweight (p < 0.001). Class I, Class II, and Class III patients with obesity revealed lower odds of respiratory failure compared to overweight (OR 0.89, 0.82, and 0.82; 95CI 0.75–1.05, 0.69–0.97, and 0.70–0.97), but failed to achieve statistical significance (p = 0.079). On multivariable regression analysis, all-cause in-hospital mortality revealed significantly higher odds in patients with Class III obesity, Class II, and Class I (OR 1.56, 1.17, and 1.06; 95CI 1.34–1.81, 0.99–1.38, and 0.91–1.24) vs. overweight patients (p < 0.001). Patients with Class II and Class III obesity had significantly higher odds of MACCE and in-hospital mortality in COVID-19-severe sepsis admissions.

14 October 2025 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Open access
MNMuhammad Abdullah Naveed
Muhammad Abdullah Naveed
SNSivaram Neppala
Sivaram Neppala
AAAhila Ali
Ahila Ali
MRMuhammad Omer Rehan
Muhammad Omer Rehan
HNHamza Naveed
Hamza Naveed
MMMuhammad Bilal Munir
Muhammad Bilal Munir
Background: Atrial fibrillation (AF) is a prevalent arrhythmia that frequently coexists with cardiomyopathy, leading to deteriorated cardiovascular outcomes. Analyzing the trends associated with these conditions is essential for improving prevention strategies and management practices. Methods: CDC WONDER (1999–2023) data were analyzed to assess AF with cardiomyopathy‐related mortality in patients aged ≥ 25. Using Joinpoint regression analysis, we calculated age‐adjusted mortality rates (AAMRs) per 100,000 patients and average annual percentage changes (AAPCs) to analyze mortality trends. Results: AF with cardiomyopathy is responsible for 126,377 deaths among adults aged 25 and older. Alarmingly, AAMRs have surged from 1.8 per 100,000 in 1999 to 3.0 in 2023 (AAPC: 2.11, p < 0.001). The upward trend remains pronounced, particularly between 2016 and 2021, with an annual percentage change of 6.17 ( p = 0.02). Disparities in mortality rates are striking. Men face a higher AAMR than women (3.1 vs. 1.5), and Black individuals bear the heaviest burden at 2.4, closely followed by Whites at 2.3. Regionally, Vermont stands out with the highest AAMR at 3.6, while New York reports the lowest at 1.3. Both rural and urban areas maintain equal AAMRs of 2.1, yet the increase in rural regions is particularly concerning, reflecting an AAPC of 2.44 compared to 1.78 in urban settings. Conclusion: The rising mortality rates from AF with cardiomyopathy in patients, particularly among men, Black individuals, and rural residents, demand urgent action. These concerning trends underscore a public health crisis that must be addressed.